Clinical Trial Update: Phase I Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of GSK2256098 in Healthy Volunteers [Phase 1]

View source ↗

Summary

This clinical trial update summarizes completion of a Phase I study assessing safety, pharmacokinetics and pharmacodynamics of GSK2256098 in healthy volunteers.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• GSK2256098

Snippet

Sponsor: GlaxoSmithKline | Conditions: Cancer | Phase 1 | Status: COMPLETED